About this trial
Most psychiatric research is based on the nosographic classifications used in current practice. At present, there is no diagnostic or prognostic biomarker for psychiatric pathologies commonly used in clinical practice. The study hypothesis is that peripheral inflammatory biomarkers could be common to several psychiatric disorders, in particular psychotic disorders (bipolar disorder, schizophreniform disorder, schizophrenia, depressive episode with psychotic features). The aim of this project is to set up a bio-collection of biological samples (peripheral blood samples) with associated phenotypic data (assessment of various symptoms using standardized scales in patients whose blood is sampled). The setting up of this cohort follows on from work carried out on a PsyCourse cohort also using a transdiagnostic approach in psychiatry, in order to be able to collaborate within a European research project.
Eligibility criteria
Qualifiers
Major patient
Characterized depressive episode with psychotic features,
Bipolar disorder type I
Bipolar disorder type II
Disqualifiers
Pregnant,
History of cancer in the last 5 years,
Vaccination within the last 4 weeks,
Acute or chronic infection,
Trial design
Treatments tested in this trial
- Peripheral venipuncture blood sampling, as part of standard care procedures
- Interview with a psychiatrist
Treatment groups
Sponsors and collaborators
Nantes University Hospital
Lead sponsor
CR2TI, INSERM, UMR1064
Collaborator